SML3653
Triptorelin pamoate
≥95% (HPLC)
别名:
Pyr-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2 pamoate salt, Triptorelin ebonate, [D-Trp6]-LH-RH pamoate
质量水平
方案
≥95% (HPLC)
表单
(Powder or lyophilized powder or film)
分子量
1311.45 g/mol
储存条件
desiccated
颜色
white to off-white
储存温度
-10 to -25°C
SMILES字符串
OC1=C(CC2=C(O)C(C(O)=O)=CC3=C2C=CC=C3)C4=C(C=CC=C4)C=C1C(O)=O.O=C([C@H](CC5)NC5=O)N[C@@H](CC6=CN=CN6)C(N[C@@H](CC7=CNC8=C7C=CC=C8)C(N[C@@H](CO)C(N[C@@H](CC9=CC=C(O)C=C9)C(N[C@H](CC%10=CNC%11=C%10C=CC=C%11)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N%12[C@H](
生化/生理作用
Synthetic LHRH agonist analog
Triptorelin pamoate is a synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH). It is used clinically to treat prostate cancer and precocious puberty in boys and girls.
免责声明
Hygroscopic
警示用语：
Danger
危险声明
危险分类
Repr. 1B
储存分类代码
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
监管及禁止进口产品
此项目有
历史批次信息供参考:
分析证书(COA)
Lot/Batch Number
Triptorelin relieves lower urinary tract symptoms in Chinese advanced prostate cancer patients: a multicenter, non-interventional, prospective study
BMC Urology, 18(1), 23-23 (2018)
Giulia Marvaso et al.
Anticancer research, 38(5), 3139-3143 (2018-05-02)
Patients with locally advanced prostate cancer are generally treated with radiotherapy (RT) which can be combined with hormonal therapy. RT plus monotherapy with luteinizing hormone-releasing hormone (LHRH) analog triptorelin was compared to RT plus total androgen block (TAB). A retrospective
Delphine Zenaty et al.
Hormone research in paediatrics, 86(3), 188-195 (2016-11-02)
To evaluate the efficacy and safety of a triptorelin pamoate (11.25 mg) 3-month formulation in the management of central precocious puberty (CPP) (TP Study) and to retrospectively compare it with a triptorelin acetate (11.25 mg) 3-month formulation (TA Study). We
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持